DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain

[1]  J. Kennedy,et al.  Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. , 2007, The international journal of neuropsychopharmacology.

[2]  B. Bondy,et al.  Pharmacogenetics of antipsychotics: useful for the clinician? , 2007, Current opinion in psychiatry.

[3]  G. Reynolds,et al.  The 5-HT2C receptor and antipsychoticinduced weight gain – mechanisms and genetics , 2006, Journal of psychopharmacology.

[4]  R. Ebstein.  The molecular genetic architecture of human personality: beyond self-report questionnaires , 2006, Molecular Psychiatry.

[5]  S. Kasper,et al.  A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study. , 2005, Journal of psychiatric research.

[6]  B. Kinon,et al.  Association Between Early and Rapid Weight Gain and Change in Weight Over One Year of Olanzapine Therapy in Patients with Schizophrenia and Related Disorders , 2005, Journal of clinical psychopharmacology.

[7]  Del D. Miller,et al.  Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapine , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  G. Reynolds,et al.  Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis , 2005, Pharmacogenetics and genomics.

[9]  Del D. Miller,et al.  Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphism , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[10]  P. Muglia,et al.  The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: An evolutionary perspective , 2004, Biological Psychiatry.

[11]  L. Kahn,et al.  The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) , 2003, Psychoneuroendocrinology.

[12]  Tao Li,et al.  Association of the 5-HT2c gene with susceptibility and minimum body mass index in anorexia nervosa , 2003, Neuroreport.

[13]  Abraham Weizman,et al.  DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study , 2003, European Neuropsychopharmacology.

[14]  L. Kahn,et al.  Hormonal aspects of schizophrenias: an overview , 2003, Psychoneuroendocrinology.

[15]  G. Reynolds,et al.  Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. , 2003, The American journal of psychiatry.

[16]  J. Salamone,et al.  Nucleus Accumbens Dopamine and the Regulation of Effort in Food-Seeking Behavior: Implications for Studies of Natural Motivation, Psychiatry, and Drug Abuse , 2003, Journal of Pharmacology and Experimental Therapeutics.

[17]  G. Reynolds,et al.  Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism , 2002, The Lancet.

[18]  C. Gillberg,et al.  Association between a Polymorphism of the 5-HT2C Receptor and Weight Loss in Teenage Girls , 2002, Neuropsychopharmacology.

[19]  R. Weizman,et al.  Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  B. N. Jones,et al.  Psychiatric Medication for Older Adults: The Concise Guide , 2001 .

[21]  O. Blin,et al.  Antipsychotic-associated weight gain and clinical outcome parameters. , 2001, The Journal of clinical psychiatry.

[22]  G. Tollefson,et al.  Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. , 2001, The Journal of clinical psychiatry.

[23]  Ming D. Li,et al.  Regulation of feeding-associated peptides and receptors by nicotine , 2000, Molecular Neurobiology.

[24]  M. Heo,et al.  Antipsychotic-induced weight gain: a comprehensive research synthesis. , 1999, The American journal of psychiatry.

[25]  S. Marder,et al.  Novel antipsychotics: comparison of weight gain liabilities. , 1999, The Journal of clinical psychiatry.

[26]  Paul J. Harrison,et al.  Allelic variation in the 5-HT2C receptor (HTR2C) and functional responses to the 5-HT2C receptor agonist, m-chlorophenylpiperazine , 1999, Psychopharmacology.

[27]  T. Meehan,et al.  Weight Changes during Clozapine Treatment , 1998, The Australian and New Zealand journal of psychiatry.

[28]  S. Stahl.  Neuropharmacology of obesity: my receptors made me eat it. , 1998, The Journal of clinical psychiatry.

[29]  F. Frankenburg,et al.  Clozapine and body mass change , 1998, Biological Psychiatry.

[30]  H. Möller,et al.  Efficacy and side‐effects of clozapine not associated with variation in the 5‐HT2C receptor , 1997, Neuroreport.

[31]  R. Eglen,et al.  RS-102221: A Novel High Affinity and Selective, 5-HT2C Receptor Antagonist , 1997, Neuropharmacology.

[32]  H. Möller,et al.  Efficacy and Side-Effects of Clozapine: Testing for Association with Allelic Variation in the Dopamine D4 Receptor Gene , 1996, Neuropsychopharmacology.

[33]  D. Goldman,et al.  Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). , 1995, Genomics.

[34]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[35]  S. Cichon,et al.  Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. , 1994, Human molecular genetics.

[36]  P. Seeman,et al.  Multiple dopamine D4 receptor variants in the human population , 1992, Nature.

[37]  B. Tang,et al.  Caffeine as a metabolic probe: Exploration of the enzyme‐inducing effect of cigarette smoking , 1991, Clinical pharmacology and therapeutics.

[38]  D. Goldman,et al.  Modification of human 5-HT2C receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution , 2004, Molecular Psychiatry.

[39]  J. Lieberman,et al.  Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. , 2001, The Journal of clinical psychiatry.

[40]  B. Jones,et al.  Weight change and atypical antipsychotic treatment in patients with schizophrenia. , 2001, The Journal of clinical psychiatry.

[41]  B. Cohen,et al.  Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs , 1999, Psychopharmacology.

[42]  R. Leadbetter,et al.  Clozapine-induced weight gain: prevalence and clinical relevance. , 1992, The American journal of psychiatry.